EC Number | Application | Comment | Organism |
---|---|---|---|
3.2.1.20 | medicine | enzyme inhibition as therapeutic target for diabetes, in cancer, viral infections and in lysosomal storage diseases | Rattus norvegicus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.2.1.20 | (4R,4aR,8aS)-4-[(E)-2-(furan-3-yl)ethenyl]-2-hydroxy-3,4a,8,8-tetramethyl-4a,5,6,7,8,8a-hexahydronaphthalen-1(4H)-one | - |
Rattus norvegicus | |
3.2.1.20 | (4R,4aR,8aS)-4-[(E)-2-(furan-3-yl)ethenyl]-3,4a,8,8-tetramethyl-1-oxo-1,4,4a,5,6,7,8,8a-octahydronaphthalen-2-yl acetate | - |
Rattus norvegicus | |
3.2.1.20 | (4R,4aR,8aS)-4-[(E)-2-(furan-3-yl)ethenyl]-3-(hydroxymethyl)-4a,8,8-trimethyl-4a,5,6,7,8,8a-hexahydronaphthalen-1(4H)-one | - |
Rattus norvegicus | |
3.2.1.20 | (4S,4aR,8aS)-4-[(E)-2-(furan-3-yl)ethenyl]-3,4a,8,8-tetramethyl-4a,5,6,7,8,8a-hexahydronaphthalen-1(4H)-one | - |
Rattus norvegicus | |
3.2.1.20 | 4-[(E)-2-[(1S,4aS,8aR)-2,5,5,8a-tetramethyl-4-oxo-1,4,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]ethenyl]furan-2(5H)-one | - |
Rattus norvegicus | |
3.2.1.20 | Hedychia lactone B | - |
Rattus norvegicus | |
3.2.1.20 | Spicatanol | - |
Rattus norvegicus | |
3.2.1.20 | Spicatanol methyl ether | - |
Rattus norvegicus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.2.1.20 | Rattus norvegicus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.2.1.20 | intestine | - |
Rattus norvegicus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.2.1.20 | 4-nitrophenyl alpha-D-glucopyranoside + H2O | - |
Rattus norvegicus | 4-nitrophenol + alpha-D-glucose | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.2.1.20 | alpha-glucosidase | - |
Rattus norvegicus |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
3.2.1.20 | additional information | - |
0.1 mg/ml, 11.3% enzyme inhibition | Rattus norvegicus | Hedychia lactone B | |
3.2.1.20 | additional information | - |
0.1 mg/ml, 13.5% enzyme inhibition | Rattus norvegicus | (4R,4aR,8aS)-4-[(E)-2-(furan-3-yl)ethenyl]-2-hydroxy-3,4a,8,8-tetramethyl-4a,5,6,7,8,8a-hexahydronaphthalen-1(4H)-one | |
3.2.1.20 | additional information | - |
0.1 mg/ml, 15.1% enzyme inhibition | Rattus norvegicus | (4R,4aR,8aS)-4-[(E)-2-(furan-3-yl)ethenyl]-3-(hydroxymethyl)-4a,8,8-trimethyl-4a,5,6,7,8,8a-hexahydronaphthalen-1(4H)-one | |
3.2.1.20 | additional information | - |
0.1 mg/ml, 25.7% enzyme inhibition | Rattus norvegicus | (4R,4aR,8aS)-4-[(E)-2-(furan-3-yl)ethenyl]-3,4a,8,8-tetramethyl-1-oxo-1,4,4a,5,6,7,8,8a-octahydronaphthalen-2-yl acetate | |
3.2.1.20 | additional information | - |
0.1 mg/ml, 35.1% enzyme inhibition | Rattus norvegicus | 4-[(E)-2-[(1S,4aS,8aR)-2,5,5,8a-tetramethyl-4-oxo-1,4,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]ethenyl]furan-2(5H)-one | |
3.2.1.20 | additional information | - |
0.1 mg/ml, 54.1% enzyme inhibition | Rattus norvegicus | Spicatanol methyl ether | |
3.2.1.20 | additional information | - |
0.1 mg/ml, 55.6% enzyme inhibition | Rattus norvegicus | (4S,4aR,8aS)-4-[(E)-2-(furan-3-yl)ethenyl]-3,4a,8,8-tetramethyl-4a,5,6,7,8,8a-hexahydronaphthalen-1(4H)-one | |
3.2.1.20 | 0.0341 | - |
0.1 mg/ml, 89.5% enzyme inhibition | Rattus norvegicus | Spicatanol |